Dr. Richard Stone, MD
Claim this profileDana Farber Cancer Institute
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
7 reported clinical trials
11 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
NPM1 positive
FLT3 positive
-5q positive
2Acute Myeloid Leukemia
FLT3 positive
NPM1 positive
-5q positive
Affiliated Hospitals
Clinical Trials Richard Stone, MD is currently running
Venetoclax + Chemotherapy
for Acute Myeloid Leukemia
This research study is studying the combination of venetoclax and chemotherapy as a possible treatment for acute myelogenous leukemia (AML). The drugs involved in this study are: * Venetoclax * Daunorubicin * Cytarabine
Recruiting1 award Phase 116 criteria
Revumenib + Standard Treatments
for Acute Myeloid Leukemia
This research is being conducted to determine a safe and effective dose of revumenib that can be given in combination with standard induction (initial therapy to induce a remission) + FLT3 targeted therapy (midostaurin) and a single cycle of post-remission therapy + FLT3 targeted therapy (midostaurin) to participants with newly diagnosed Nucleophosmin (NPM1) and FMS-like tyrosine kinase 3 (FLT3) mutated Acute Myeloid Leukemia (AML). The names of the study drugs involved in this study are: * Revumenib (SNDX-5613) (a type of menin inhibitor) * Midostaurin (a type of multi-kinase including FLT3 inhibitor) * Cytarabine (a type of antineoplastic agent) * Daunorubicin (a type of antineoplastic agent)
Recruiting1 award Phase 1
More about Richard Stone, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Richard Stone, MD has experience with
- Cytarabine
- Daunorubicin
- Midostaurin
- Venetoclax
- PKC412
- RAD001
Breakdown of trials Richard Stone, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Stone, MD specialize in?
Richard Stone, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved NPM1 positive patients, or patients who are FLT3 positive.
Is Richard Stone, MD currently recruiting for clinical trials?
Yes, Richard Stone, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Richard Stone, MD has studied deeply?
Yes, Richard Stone, MD has studied treatments such as Cytarabine, Daunorubicin, Midostaurin.
What is the best way to schedule an appointment with Richard Stone, MD?
Apply for one of the trials that Richard Stone, MD is conducting.
What is the office address of Richard Stone, MD?
The office of Richard Stone, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.